| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Editorial Board
|
|
|
|
32 |
15 |
p. i
|
artikel
|
| 2 |
French AFU Cancer Committee Guidelines Update 2022–2024: Adrenal tumor – Assessment of an adrenal incidetaloma and oncological management
|
Savoie, P.H.
|
|
|
32 |
15 |
p. 1040-1065
|
artikel
|
| 3 |
French AFU Cancer Committee Guidelines - Update 2022-2024: management of kidney cancer
|
Bigot, P.
|
|
|
32 |
15 |
p. 1195-1274
|
artikel
|
| 4 |
French AFU Cancer Committee Guidelines – Update 2022–2024: Muscle-Invasive Bladder Cancer (MIBC)
|
Neuzillet, Y.
|
|
|
32 |
15 |
p. 1141-1163
|
artikel
|
| 5 |
French AFU Cancer Committee Guidelines - Update 2022-2024: Non-muscle-invasive bladder cancer (NMIBC)
|
Neuzillet, Y.
|
|
|
32 |
15 |
p. 1102-1140
|
artikel
|
| 6 |
French AFU Cancer Committee Guidelines - Update 2022-2024: penile cancer
|
Savoie, P.H.
|
|
|
32 |
15 |
p. 1010-1039
|
artikel
|
| 7 |
French AFU Cancer Committee Guidelines - Update 2022-2024: prostate cancer - Diagnosis and management of localised disease
|
Ploussard, G.
|
|
|
32 |
15 |
p. 1275-1372
|
artikel
|
| 8 |
French AFU Cancer Committee Guidelines - Update 2022-2024: prostate cancer - Management of metastatic disease and castration resistance
|
Ploussard, G.
|
|
|
32 |
15 |
p. 1373-1419
|
artikel
|
| 9 |
French AFU Cancer Committee Guidelines - Update 2022-2024: testicular germ cell cancer
|
Murez, T.
|
|
|
32 |
15 |
p. 1066-1101
|
artikel
|
| 10 |
French AFU Cancer Committee Guidelines – Update 2022–2024: Upper urinary tract urothelial cancer (UTUC)
|
Neuzillet, Y.
|
|
|
32 |
15 |
p. 1164-1194
|
artikel
|
| 11 |
Recommandations françaises du comité de cancérologie de l’AFU – actualisation 2022–2024
|
Rouprêt, M.
|
|
|
32 |
15 |
p. 1009
|
artikel
|
Tijdschrift beschrijving